The short answer
Private-banking arms of the big banks, insurer-affiliated banks, and a few credit unions and specialty lenders run IFA programs in Canada. Published programs advance up to 100 percent of whole life cash value and up to 90 percent of universal life in eligible accounts, often on floating-rate, annually reviewed demand facilities. Every number is program-specific.
ifaEvery immediate financing arrangement illustration quietly assumes a lender: a specific advance ratio, a specific rate, a facility that renews every year for decades. The lender is the least discussed and most decisive party in the structure, because the bank's credit policy, not the insurer's illustration, sets how much capital actually comes back and on what terms. This post maps the Canadian lending landscape as of this writing: who lends, what the published programs advance, and the terms behind the ratios. None of it is a quote. Programs change, appetite changes, and your own numbers come from a lender, not from a blog post.
The direct answer: three families of lenders run this market: the private-banking arms of the major banks, insurer-affiliated banks, and a small group of credit unions and specialty lenders; the insurers themselves generally arrange these loans through external lenders rather than making them.
The most detailed public program is BMO Private Banking's leveraged life insurance program, whose published advisor guide states its lending parameters plainly, and Equitable Bank publishes its own IFA materials. Insurer-affiliated banks are the second family: Manulife Bank runs a specialized lending group that takes life insurance cash value from a list of approved carriers as collateral. The third family is credit unions and specialty lenders: DUCA's specialized lending division in Ontario markets immediate financing arrangements by name, and Equitable Bank publishes a dedicated IFA within its insurance lending line, built around large whole life premiums with its partner insurers. One correction to a common shortcut: the insurers themselves generally do not make these loans. Equitable Life's collateral loan program, for instance, is a set of arrangements with external lenders, Manulife Bank, Scotia Wealth, and specialty lender Gracie Point among them. Borrowing directly from the insurer is a policy loan, a different instrument with different tax treatment, covered in the IFA guide. (Disclosure, because this market touches how I am paid: I am a licensed insurance and investment advisor, and placing corporately owned policies is part of how I am compensated. Lender introductions are part of the work; the lending decision is always the bank's.)
The list is short on purpose. This is specialty credit: each program has its own minimum size, its own approved-carrier list, and its own appetite that expands and contracts with credit conditions. Whoever you talk to, the current answer comes from asking.
The direct answer: published margin ratios run up to 100 percent of cash surrender value for whole life and up to 90 percent for universal life in eligible accounts, while separate premium-based designs advance against premiums paid on their own conditions.
BMO's published program advances within 100 percent of a whole life policy's cash surrender value, and up to 90 percent for universal life. The UL figure carries qualifiers that decide real cases: BMO margins universal life held in specified guaranteed and indexed accounts, subject to conditions that include a cap on combined equity exposure of 30 percent. Push past the eligible allocations and the lending value shrinks or disappears, because collateral that can fall 30 percent in a bad year is not collateral a demand lender prices kindly. Participating whole life earns the top ratios for the mirror-image reason: insurer-declared, smoothed values that do not reprice daily.
Two different yardsticks are in play here, and conflating them causes most of the confusion in this market. The margin ratios above are percentages of cash surrender value. Premium-based advances are a separate design: BMO's front-end leveraging lends up to 100 percent of deposits and premiums paid, taking additional security wherever the cash value margin falls short, and Equitable Bank's IFA advances up to 100 percent of the annual premium on eligible whole life policies with its partner insurers, without additional collateral. In a policy's first years, cash value and cumulative premiums are very different numbers, which is exactly where the next section lives.
The direct answer: early-year cash value sits below cumulative premiums, so a full-premium advance in year one comes from a premium-based design: front-end leveraging against additional security, or a program built to advance the full premium on eligible policies.
A labeled hypothetical, structure only: a corporation pays a $100,000 first-year premium and the policy's first-year cash surrender value comes to $65,000. At a 100 percent whole life margin the policy alone supports a $65,000 advance, not $100,000. The published answers to that gap take three shapes. Front-end leveraging: BMO's guide describes advancing up to 100 percent of premiums paid, with additional security, investment accounts or deposits, held until the cash value margin covers the loan by itself, at which point the side collateral is released. Full-premium programs: Equitable Bank's IFA advances up to 100 percent of the annual premium on eligible whole life designs with partner insurers, pricing the early-year gap into the program instead of into your collateral. Or simply advancing less in the early years. Either way, the sales-line version, borrow every premium dollar back from day one, has a real structure behind it and a real cost: side collateral tied up, program eligibility limits, or a smaller early advance. How fast cash value catches up to cumulative premiums is a carrier and design question, which is one more reason the policy has to be one the corporation would want on its own merits before the leverage.
The direct answer: often a floating-rate demand facility reviewed annually, though term loans and lines of credit exist across the market, with margin maintenance and program-specific minimums and fees throughout, all of which can move against you while the insurance commitment cannot move at all.
BMO's published facility is a demand loan at floating rates, priced off prime with a client-specific spread and reviewed annually, with fixed-rate options available on larger loans. Other programs are structured differently: term loans and lines of credit with their own payment and amortization terms appear across the market, and Equitable Life's overview of its third-party arrangements lists several such structures. Wherever a review exists, it is not ceremonial: the lender re-checks the collateral margin, the borrower's finances, and its own appetite, and can reprice, trim the advance ratio, require paydown, or decline to renew. Margin maintenance runs continuously; a loan that outgrows its collateral triggers a call for security or repayment. Dedicated programs carry minimums, commonly framed around annual premium size, and setup involves legal and administrative fees; both are program-specific and current only from the lender. Set the two commitments side by side and the asymmetry is the risk: the insurance premium is a decades-long obligation, while the loan that funds the strategy is repriced and re-approved on the lender's cycle, and in the common demand structure is callable outright. The step-by-step worked example prices one year of that pairing; every year after it is a renewal.
The direct answer: participating whole life generally borrows at the top ratios; universal life borrows well only when its investments sit in accounts the lender accepts, guaranteed and capped indexed allocations in the published program, so the product choice and the leverage plan have to be made together.
Advisors usually frame the PAR-versus-UL choice around policy features. The lending desk frames it around collateral quality, and for an IFA the lending desk's frame governs. Smoothed participating values earn the 100 percent treatment. A UL policy borrowed against at 90 percent in eligible accounts is competitive; push the allocation past the lender's equity cap and the same policy may borrow at a fraction of that or not at all, and reallocating later to fix the ratio changes the investment thesis the policy was bought on. A corporation planning to leverage should get the intended lender's collateral treatment for each design in writing before the policy is placed, not after.
The direct answer: the lender takes a collateral assignment of the policy with the insurer's acknowledgment, and that lender-required assignment is one of the statutory conditions for the small collateral insurance deduction.
Every program in this market takes the same core security: a collateral assignment of the policy, acknowledged by the insurer so the lender holds a priority claim on the cash value and death benefit. That requirement does quiet tax work. Paragraph 20(1)(e.2) allows the capped collateral insurance deduction only where the assignment was to a restricted financial institution and the lender required it as a condition of the borrowing, alongside the interest-deductibility condition covered in the interest post. Keeping the borrower, the policy owner, and the income-earning use inside the same corporation keeps the rest of the structure clean. The IFA comparison tool will price a year of whatever terms a lender actually quotes you, and whether the whole arrangement belongs in your plan is the suitability conversation described in financial planning for physicians: it starts with cash flow that survives the rate cycle and a lender saying no, because sooner or later one of them will.
Three families. The private-banking arms of major banks, BMO Private Banking being the one with a published advisor program guide. Insurer-affiliated banks, such as Manulife Bank's specialized lending group. And credit unions and specialty lenders: DUCA's specialized lending division and Equitable Bank, whose insurance lending line includes a documented IFA. The insurers themselves generally do not make these loans; Equitable Life's collateral loan program, for example, connects policyholders with external lenders. Availability, minimums, and appetite change; the current list comes from asking, not from any static roundup.
Published programs advance up to 100 percent of a whole life policy's cash surrender value, and up to 90 percent for universal life held in eligible accounts, BMO's guide specifying guaranteed and certain indexed accounts with a cap on combined equity exposure. Equity-heavy allocations reduce or eliminate lending value. Those margin ratios apply to cash value; separate premium-based designs, front-end leveraging and full-premium IFA programs, advance against premiums paid on their own conditions.
Sometimes, but usually not on the policy alone. Early-year cash value sits below cumulative premiums, so a full-premium advance in the first years is front-end leveraging: the lender advances up to 100 percent of premiums paid but requires additional security, investments or deposits, until the policy's cash value grows to cover the loan on its own. Without side collateral, the advance is capped by the cash value margin.
It depends on the structure. BMO's published facility is a demand loan reviewed yearly: the lender re-checks the cash value margin, the corporation's finances, and its own program appetite, and can reprice, reduce the advance ratio, require paydown, or decline to renew. Other programs run as term loans or lines of credit with their own review and repayment terms. Either way, a plan that only works if the bank always says yes is not a plan, which is why the exit arithmetic belongs in the original decision.
